Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung Ju Ryu

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|July 7, 2018
Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphomaSung Won Lim, Kyung Ju Ryu, Hansang Lee, et al.
Oncotarget|November 5, 2017
Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphomaJun Soo Ham, Ha Young Park, Kyung Ju Ryu, et al.
Cytokine|March 6, 2020
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphomaJun Ho Yi, Sang Eun Yoon, Kyung Ju Ryu, et al.
Cancers|November 26, 2022
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell LymphomaSeok Jin Kim, Kyung Ju Ryu, Bon Park, et al.
Oncotarget|January 19, 2017
Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOPJung Yong Hong, Kyung Ju Ryu, Chaehwa Park, et al.
BMC Cancer|February 15, 2020
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphomaInju Cho, Hansang Lee, Sang Eun Yoon, et al.
Hematological Oncology|December 13, 2016
Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphomaJung Yong Hong, Kyung Ju Ryu, Ji Yean Lee, et al.
Frontiers in Oncology|November 30, 2023
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphomaSang Eun Yoon, Sujin Park, Junhun Cho, et al.
Scientific Reports|February 25, 2025
MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphomaKyung Ju Ryu, Haein Ji, Bon Park, et al.
Hematological Oncology|March 2, 2016
Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphomaHae Su Kim, Kyung Ju Ryu, Young Hyeh Ko, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|July 7, 2018
Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphomaSung Won Lim, Kyung Ju Ryu, Hansang Lee, et al.
Oncotarget|November 5, 2017
Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphomaJun Soo Ham, Ha Young Park, Kyung Ju Ryu, et al.
Cytokine|March 6, 2020
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphomaJun Ho Yi, Sang Eun Yoon, Kyung Ju Ryu, et al.
Cancers|November 26, 2022
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell LymphomaSeok Jin Kim, Kyung Ju Ryu, Bon Park, et al.
Oncotarget|January 19, 2017
Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOPJung Yong Hong, Kyung Ju Ryu, Chaehwa Park, et al.
BMC Cancer|February 15, 2020
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphomaInju Cho, Hansang Lee, Sang Eun Yoon, et al.
Hematological Oncology|December 13, 2016
Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphomaJung Yong Hong, Kyung Ju Ryu, Ji Yean Lee, et al.
Frontiers in Oncology|November 30, 2023
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphomaSang Eun Yoon, Sujin Park, Junhun Cho, et al.
Scientific Reports|February 25, 2025
MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphomaKyung Ju Ryu, Haein Ji, Bon Park, et al.
Hematological Oncology|March 2, 2016
Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphomaHae Su Kim, Kyung Ju Ryu, Young Hyeh Ko, et al.
Pageof 4